Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

GLN-GABAPENTIN

GLENMARK PHARMACEUTICALS CANADA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of GLN-GABAPENTIN in Canada?

A shortage of GLN-GABAPENTIN 600MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated May 27, 2026), but it has not started yet.

When will GLN-GABAPENTIN be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file6 products
Affected strength600MG
Last updated2026-05-27

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

TEVA-GABAPENTIN

TEVA CANADA LIMITED

600MG · DIN 02248457

Same strengthDifferent dosage formSame routeNo current shortage

NTP-GABAPENTIN

TEVA CANADA LIMITED

600MG · DIN 02384973

Same strengthDifferent dosage formSame routeNo current shortage

NEURONTIN

BGP PHARMA ULC

100MG · DIN 02084260

Different strengthDifferent dosage formSame routeNo current shortage

GABAPENTIN

OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC.

100MG · DIN 02238671

Different strengthDifferent dosage formSame routeNo current shortage

APO-GABAPENTIN

APOTEX INC

300MG · DIN 02244305

Different strengthDifferent dosage formSame routeNo current shortage

DOM-GABAPENTIN

DOMINION PHARMACAL

400MG · DIN 02243745

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02410990

Strength

600MG

Dosage Form

TABLET TABLET (IMMEDIATE RELEASE)

Route

ORAL

Active Ingredient

GABAPENTIN

See all GABAPENTIN products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History